302 related articles for article (PubMed ID: 26367092)
21. Cerebrospinal fluid interleukin-10 is a potentially useful biomarker in immunocompetent primary central nervous system lymphoma (PCNSL).
Sasayama T; Nakamizo S; Nishihara M; Kawamura A; Tanaka H; Mizukawa K; Miyake S; Taniguchi M; Hosoda K; Kohmura E
Neuro Oncol; 2012 Mar; 14(3):368-80. PubMed ID: 22156547
[TBL] [Abstract][Full Text] [Related]
22. International Central Nervous System and Ocular Lymphoma Workshop: recommendations for the future.
Nussenblatt RB; Chan CC; Wilson WH; Hochman J; Gottesman M;
Ocul Immunol Inflamm; 2006 Jun; 14(3):139-44. PubMed ID: 16827214
[TBL] [Abstract][Full Text] [Related]
23. [Special hematological diagnostics and therapy options for ocular lymphoma taking CNS involvement into account].
Korfel A; Schlegel U; Schroers R
Ophthalmologe; 2015 Mar; 112(3):231-6. PubMed ID: 25721677
[TBL] [Abstract][Full Text] [Related]
24. Diagnostic delay and prognosis in primary central nervous system lymphoma compared with glioblastoma multiforme.
Cerqua R; Balestrini S; Perozzi C; Cameriere V; Renzi S; Lagalla G; Mancini G; Montanari M; Leoni P; Scerrati M; Iacoangeli M; Silvestrini M; Luzzi S; Provinciali L
Neurol Sci; 2016 Jan; 37(1):23-29. PubMed ID: 26233232
[TBL] [Abstract][Full Text] [Related]
25. Primary central nervous system lymphoma: a profile of 26 cases from Western India.
Agarwal PA; Menon S; Smruti BK; Singhal BS
Neurol India; 2009; 57(6):756-63. PubMed ID: 20139505
[TBL] [Abstract][Full Text] [Related]
26. Intraocular lymphoma: update on diagnosis and management.
Chan CC; Wallace DJ
Cancer Control; 2004; 11(5):285-95. PubMed ID: 15377987
[TBL] [Abstract][Full Text] [Related]
27. Diagnosis and treatment of primary central nervous system lymphoma.
Gavrilovic IT; Abrey LE
Curr Oncol Rep; 2005 Jan; 7(1):47-54. PubMed ID: 15610686
[TBL] [Abstract][Full Text] [Related]
28. [A case of intraocular malignant lymphoma diagnosed by immunoglobulin gene rearrangement and translocation, and IL-10/IL-6 ratio in the vitreous fluid].
Yokota M; Takase H; Imai Y; Kamoi K; Sugita S; Morita H; Takizawa T; Tanaka S; Shen DF; Chan CC; Mochizuki M
Nippon Ganka Gakkai Zasshi; 2003 May; 107(5):287-91. PubMed ID: 12784729
[TBL] [Abstract][Full Text] [Related]
29. Current concepts in diagnosing and managing primary vitreoretinal (intraocular) lymphoma.
Chan CC; Sen HN
Discov Med; 2013 Feb; 15(81):93-100. PubMed ID: 23449111
[TBL] [Abstract][Full Text] [Related]
30. [Management of primary central nervous system lymphoma].
Gonzalez-Aguilar A; Houillier C; Soussain C; Hoang-Xuan K
Rev Neurol (Paris); 2011 Oct; 167(10):721-8. PubMed ID: 21906768
[TBL] [Abstract][Full Text] [Related]
31. Current strategies in the diagnosis of diffuse large B-cell lymphoma of the central nervous system.
Baraniskin A; Deckert M; Schulte-Altedorneburg G; Schlegel U; Schroers R
Br J Haematol; 2012 Feb; 156(4):421-32. PubMed ID: 22077417
[TBL] [Abstract][Full Text] [Related]
32. Advances in Primary Central Nervous System Lymphoma.
Patrick LB; Mohile NA
Curr Oncol Rep; 2015 Dec; 17(12):60. PubMed ID: 26475775
[TBL] [Abstract][Full Text] [Related]
33. Role of vitreous cytology in the diagnosis of primary central nervous system lymphoma: A report of an unusual presentation.
Tom JP; Gupta P; Radotra BD; Gupta N; Takkar A; Singh S; Gupta V
Diagn Cytopathol; 2023 Aug; 51(8):E232-E238. PubMed ID: 37148480
[TBL] [Abstract][Full Text] [Related]
34. The Cleveland Clinic experience with primary central nervous system lymphoma.
Xie H; Ahluwalia MS; Peereboom DM
Am J Clin Oncol; 2015 Apr; 38(2):140-6. PubMed ID: 23608829
[TBL] [Abstract][Full Text] [Related]
35. CSF neopterin level as a diagnostic marker in primary central nervous system lymphoma.
Viaccoz A; Ducray F; Tholance Y; Barcelos GK; Thomas-Maisonneuve L; Ghesquières H; Meyronet D; Quadrio I; Cartalat-Carel S; Louis-Tisserand G; Jouanneau E; Guyotat J; Honnorat J; Perret-Liaudet A
Neuro Oncol; 2015 Nov; 17(11):1497-503. PubMed ID: 26014047
[TBL] [Abstract][Full Text] [Related]
36. Diagnosis of central nervous system lymphoma via cerebrospinal fluid cytology: a case report.
Zhao H; Ma M; Zhang L; Zheng G; Lv H; Liu J; Li X; Song B; Zhang G
BMC Neurol; 2019 May; 19(1):90. PubMed ID: 31064334
[TBL] [Abstract][Full Text] [Related]
37. Expression of Tim-1 in primary CNS lymphoma.
Kishimoto W; Nishikori M; Arima H; Miyoshi H; Sasaki Y; Kitawaki T; Shirakawa K; Kato T; Imaizumi Y; Ishikawa T; Ohno H; Haga H; Ohshima K; Takaori-Kondo A
Cancer Med; 2016 Nov; 5(11):3235-3245. PubMed ID: 27709813
[TBL] [Abstract][Full Text] [Related]
38. Primary CNS Lymphoma.
Grommes C; DeAngelis LM
J Clin Oncol; 2017 Jul; 35(21):2410-2418. PubMed ID: 28640701
[TBL] [Abstract][Full Text] [Related]
39. [Intraocular non-Hodgkin's lymphoma and its therapy-- a case series of ten patients].
Siepmann K; Rohrbach JM; Duncker G; Zierhut M
Klin Monbl Augenheilkd; 2004 Apr; 221(4):266-72. PubMed ID: 15118956
[TBL] [Abstract][Full Text] [Related]
40. Modern concepts in the biology, diagnosis, differential diagnosis and treatment of primary central nervous system lymphoma.
Deckert M; Engert A; Brück W; Ferreri AJ; Finke J; Illerhaus G; Klapper W; Korfel A; Küppers R; Maarouf M; Montesinos-Rongen M; Paulus W; Schlegel U; Lassmann H; Wiestler OD; Siebert R; DeAngelis LM
Leukemia; 2011 Dec; 25(12):1797-807. PubMed ID: 21818113
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
